Lasa Supergenerics Limited, India’s Leading API Manufacturer, announced that it has secured a new order of ₹500 Million from just 5 customers.
We are delighted to announce that with the efforts of our Marketing Team and the quality of product we offer we were able to grab the order of ₹ 500 Million from only 5 customers in this highly competitive market scenario. Such a huge order in the beginning of the financial year shall help the company to boost its production and contribute to the top line of Company.
Besides day-to-day business this bulk order will flood our Order Books yet again for this fiscal which shall help the Company not only to recover the losses incurred in the last financial year due to Natural Calamities but also to contribute towards bottom line and achieve even greater heights.
Commenting on this development, Dr. Omkar Herlekar, Chairman & Managing Director, Lasa Supergenerics said, “This is just the beginning of the Fiscal and our team was able to grab the opportunity. We are thankful for our customers for having such great confidence in us. This was not possible without the efforts of our production team for manufacturing such quality products with a monopolistic approach in the segment. We are looking forward to receiving such bulk orders from overseas customers in the near future. These bulk orders will contribute to the topline of the Company as well as help in improving EBITA of the Company. Moreover we are working on making all our products fully backward integrated which shall boost return on capital of the Company, we shall continue to remain committed to growth. We were excited to share the name of the customers with all our stakeholders along with other terms of the order. However, due to restrictions as imposed by NDA signed we retain the same with us and assure you for more bulk orders in coming month."
About Lasa Supergenerics Limited (www.lasalabs.com/; BSE:540702;NSE:LASA)
Founded in 2011, Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. The company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. The Company has its unit with state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 MT. The Company has over 25% of APIs exported to countries like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.
For more details please visit: www.lasalabs.com
Disclaimer: This article is a paid publication and does not have journalistic/editorial involvement of Hindustan Times. Hindustan Times does not endorse/subscribe to the content(s) of the article/advertisement and/or view(s) expressed herein. Hindustan Times shall not in any manner, be responsible and/or liable in any manner whatsoever for all that is stated in the article and/or also with regard to the view(s), opinion(s), announcement(s), declaration(s), affirmation(s) etc., stated/featured in the same.
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.